In early-stage adenocarcinoma of the cervix both CEA (range 0.3–219.9 ng/mL) and CA125 (range 2.6–317.4 U/mL) are elevated in in 10.7% (Huang et al. 2020). This evidence concerns the gene CEACAM5 and cervical adenocarcinoma.